Smith Babiaka

Dr. Smith Babiaka

University of Buea
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2023 in RSC Advances
Verified
Journal Article
Open access
PDF file
Conrad Simoben VeransoConrad Simoben Veranso
Conrad Simoben Veranso
Smith BabiakaSmith Babiaka
Smith Babiaka
AMAurélien F. A. Moumbock
Aurélien F. A. Moumbock
CNCyril T. Namba-Nzanguim
Cyril T. Namba-Nzanguim
DEDonatus Bekindaka Eni
Donatus Bekindaka Eni
Wolfgang SipplWolfgang Sippl
Wolfgang Sippl
This review uses documented studies to highlight current difficulties faced by natural product drug discovery scientists usingin silicomethods. This will provide interested scientists in this field of research an idea of what they can expect.

23 April 2021 in RSC Advances
Verified
Journal Article
Open access
PDF file
Smith BabiakaSmith Babiaka
Smith Babiaka
AMAurélien F. A. Moumbock
Aurélien F. A. Moumbock
SGStefan Günther
Stefan Günther
Fidele Ntie-KangFidele Ntie-Kang
Fidele Ntie-Kang
Cyperus rotundus L. (Nutgrass, family Cyperaceae) is a notorious weed which is widespread in temperate tropical and subtropical regions of the world. Owing to its richness and potent pharmacological activities, efforts have been devoted to identify its bioactive constituents. Since 1965, a total of about 192 compounds including terpenoids, flavonoids, stilbenes, aromatics and aliphatic fatty acids have been characterized. This review summarizes the bioactivities and mechanism of action of some of the compounds from C. rotundus L.

13 September 2021 in Natural Products and Bioprospecting
Verified
Journal Article
Open access
PDF file
OEOyere Tanyi Ebob
Oyere Tanyi Ebob
Smith BabiakaSmith Babiaka
Smith Babiaka
Fidele Ntie-KangFidele Ntie-Kang
Fidele Ntie-Kang
For the past 2 years, the coronavirus responsible for the COVID-19 infection has become a world pandemic, ruining the lives and economies of several nations in the world. This has scaled up research on the virus and the resulting infection with the goal of developing new vaccines and therapies. Natural products are known to be a rich source of lead compounds for drug discovery, including against infectious diseases caused by microbes (viruses, bacteria and fungi). In this review article, we conducted a literature survey aimed at identifying natural products with inhibitory concentrations against the coronaviruses or their target proteins, which lie below 10 µM. This led to the identification of 42 compounds belonging to the alkaloid, flavonoid, terpenoid, phenolic, xanthone and saponin classes. The cut off concentration of 10 µM was to limit the study to the most potent chemical entities, which could be developed into therapies against the viral infection to make a contribution towards limiting the spread of the disease.

1 January 2012 in Annals of Clinical Microbiology and Antimicrobials
Verified
Journal Article
Open access
PDF file
JMJames A Mbah
James A Mbah
MNMoses N Ngemenya
Moses N Ngemenya
AAAshime Louis Abawah
Ashime Louis Abawah
Smith BabiakaSmith Babiaka
Smith Babiaka
NNNubed Lina Njiki
Nubed Lina Njiki
SESimon Mn Efange
Simon Mn Efange
Background: The global burden of bacterial infections is high and has been further aggravated by increasing resistance to antibiotics. In the search for novel antibacterials, three medicinal plants: Peperomia vulcanica, Peperomia fernandopoioana (Piperaceae) and Scleria striatinux (Cyperaceae), were investigated for antibacterial activity and toxicity. Methods: Crude extracts of these plants were tested by the disc diffusion method against six bacterial test organisms followed by bio-assay guided fractionation, isolation and testing of pure compounds. The minimum inhibitory (MIC) and minimum bactericidal (MBC) concentrations were measured by the microdilution method. The acute toxicity of the active extracts and cytotoxicity of the active compound were performed in mice and mammalian cells, respectively. Results: The diameter of the zones of inhibition (DZI) of the extracts ranged from 7–13 mm on Escherichia coli and Staphylococcus aureus of which the methylene chloride:methanol [1:1] extract of Scleria striatinux recorded the highest activity (DZI = 13 mm). Twenty-nine pure compounds were screened and one, Okundoperoxide, isolated from S. striatinux, recorded a DZI ranging from 10–19 mm on S. aureus. The MICs and MBCs indicated that the Peperomias had broad-spectrum bacteriostatic activity. Toxicity tests showed that Okundoperoxide may have a low risk of toxicity with an LC50 of 46.88 μg/mL. Conclusions: The antibacterial activity of these plants supports their use in traditional medicine. The pure compound, Okundoperoxide, may yield new antibacterial lead compounds following medicinal chemistry exploration.

29 March 2025 in Biotechnology Advances
Verified
Journal Article
Open access
Ricardo LagoaRicardo Lagoa
Ricardo Lagoa
LRLogesh Rajan
Logesh Rajan
CVCristiana Violante
Cristiana Violante
Smith BabiakaSmith Babiaka
Smith Babiaka
DMDorinda Marques-da-Silva
Dorinda Marques-da-Silva
Atanas G. AtanasovAtanas G. Atanasov
Atanas G. Atanasov
Curcumin, a natural compound found in turmeric, has shown promise in treating brain-related diseases and conditions associated with aging. Curcumin has shown multiple anti-inflammatory and brain-protective effects, but its clinical use is limited by challenges like poor absorption, specificity and delivery to the right tissues. A range of contemporary approaches at the intersection with bioengineering and systems biology are being explored to address these challenges. Data from preclinical and human studies highlight various neuroprotective actions of curcumin, including the inhibition of neuroinflammation, modulation of critical cellular signaling pathways, promotion of neurogenesis, and regulation of dopamine levels. However, curcumin's multifaceted effects - such as its impact on microRNAs and senescence markers - suggest novel therapeutic targets in neurodegeneration. Tetrahydrocurcumin, a primary metabolite of curcumin, also shows potential due to its presence in circulation and its anti-inflammatory properties, although further research is needed to elucidate its neuroprotective mechanisms. Recent advancements in delivery systems, particularly brain-targeting nanocarriers like polymersomes, micelles, and liposomes, have shown promise in enhancing curcumin's bioavailability and therapeutic efficacy in animal models. Furthermore, the exploration of drug-laden scaffolds and dermal delivery may extend the pharmacological applications of curcumin. Studies reviewed here indicate that engineered dermal formulations and devices could serve as viable alternatives for neuroprotective treatments and to manage skin or musculoskeletal inflammation. This work highlights the need for carefully designed, long-term studies to better understand how curcumin and its bioactive metabolites work, their safety, and their effectiveness.

5 November 2024 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
YFYue Feng
Yue Feng
AQAmmar Qaseem
Ammar Qaseem
AMAurélien F A Moumbock
Aurélien F A Moumbock
SPShuling Pan
Shuling Pan
PKPascal A Kirchner
Pascal A Kirchner
SGStefan Günther
Stefan Günther
Streptomycetes remain an important bacterial source of natural products (NPs) with significant therapeutic promise, particularly in the fight against antimicrobial resistance. Herein, we present StreptomeDB 4.0, a substantial update of the database that includes expanded content and several new features. Currently, StreptomeDB 4.0 contains over 8500 NPs originating from ∼3900 streptomycetes, manually annotated from ∼7600 PubMed-indexed peer-reviewed articles. The database was enhanced by two in-house developments: (i) automated literature-mined NP–protein relationships (hyperlinked to the CPRiL web server) and (ii) pharmacophore-based NP–protein interactions (predicted with the ePharmaLib dataset). Moreover, genome mining was supplemented through hyperlinks to the widely used antiSMASH database. To facilitate NP structural dereplication, interactive visualization tools were implemented, namely the JSpecView applet and plotly.js charting library for predicted nuclear magnetic resonance and mass spectrometry spectral data, respectively. Furthermore, both the backend database and the frontend web interface were redesigned, and several software packages, including PostgreSQL and Django, were updated to the latest versions. Overall, this comprehensive database serves as a vital resource for researchers seeking to delve into the metabolic intricacies of streptomycetes and discover novel therapeutics, notably antimicrobial agents. StreptomeDB is publicly accessible at https://www.pharmbioinf.uni-freiburg.de/streptomedb.